Silo Pharma Inc. (SILO) Cash on Hand per Share

Corporate emblem and logo of Silo Pharma Inc. (SILO)

Prospects for psilocybin fibromyalgia treatment programs are driving future growth, while speculative risks are already priced in. Changes in cash per share demonstrate liquidity, where the current status equals 3.98. Geopolitical tensions complicate component procurement and patent protection, while strict government control over the transport of neuropsychiatric agents increases logistics costs for Silo Pharma, Inc. (SILO).

silopharma.com (SILO) - Cash Funds per Share from 04/28/2023 to 11/20/2026

Comprehensive metric breakdowns and analytics for silopharma.com (SILO)

- stock quotes and analyst forecast:
- cash position and cash flow details:
Comprehensive company analysis:silopharma.com - SILO
Flagship merchandise of Silo Pharma, Inc.

For Silo Pharma, Inc. (SILO), which develops innovative drugs, the level of liquid assets per share on the GURU.Markets platform serves as an indicator of financial viability. This metric is calculated by dividing total cash holdings by the number of shares outstanding, determining the available capital per unit of ownership. In the absence of revenue, this figure demonstrates the burn rate of reserves. A decline in these values signals the issuer's growing dependence on new external investments.